Duo Oncology
PrivateLast Round
Seed Round
Jun 9, 2026
Total Funding Raised
$9.45M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Duo Oncology is a biotechnology company that develops tumor-responsive nanomedicines to treat difficult-to-target cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Duo Oncology Comparables
Compare Duo Oncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pendrea Bio, Inc. | 79% | |
| Adcentrx Therapeutics | 73% | |
| Bristol Myers Squibb | 71% | |
Duo Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 9, 2026 | ||||
| Seed | Aug 7, 2025 | ||||
| Grant | Dec 12, 2024 | ||||
| Accelerator | Mar 21, 2024 | ||||
| Seed | Aug 7, 2023 | ||||
Grant | Apr 17, 2023 |
Key People
Founding team and executive leadership
Duo Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| LifeX Ventures | Seed |
| LifeX Global | Seed |
| Innovation Works | Seed |
| Ulu Ventures | Seed |
| SeedFolio | Seed |
| NuFund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 9, 2026
$1.4M seed round completed.
- Aug 7, 2025
$3M round led by SeedFolio.
Duo Oncology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Duo Oncology's valuation, stock price, and market status.